BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2784891)

  • 1. Modulation of arachidonic acid metabolism and cytotoxic T lymphocyte function.
    Jendrisak M; Mangino M; Peters S; Anderson C
    Transplant Proc; 1989 Feb; 21(1 Pt 1):174-7. PubMed ID: 2784891
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of cytotoxic T lymphocyte-mediated lysis by ETYA: effect independent of arachidonic acid metabolism.
    Taylor AS; Howe RC; Morrison AR; Sprecher H; Russell JH
    J Immunol; 1985 Feb; 134(2):1130-5. PubMed ID: 2981259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New method of immunosuppression by selective destruction of CTL by a photodynamic effect.
    Satomi S; Sakurada M; Morimoto K; Satake M; Ohtsuki S; Takeda Y; Amada N; Taguchi Y; Mori S
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1134-6. PubMed ID: 2650078
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of oxygen in T cell-mediated cytolysis.
    Nathan CF; Mercer-Smith JA; Desantis NM; Palladino MA
    J Immunol; 1982 Nov; 129(5):2164-71. PubMed ID: 6981672
    [No Abstract]   [Full Text] [Related]  

  • 5. Phorbol esters inactivate the lytic apparatus of cytotoxic T lymphocytes.
    Russell JH
    J Immunol; 1984 Aug; 133(2):907-12. PubMed ID: 6610713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of adhesion. A novel and distinct effect of the cytotoxic T lymphocyte-target interaction.
    Russell JH; Musil L; McCulley DE
    J Immunol; 1988 Jan; 140(2):427-32. PubMed ID: 3121743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The optimal activation of cytotoxic T lymphocytes requires metabolically intact stimulator cells not only for the activation of the interleukin 2-producing helper cells.
    Dröge W; Männel D; Falk W; Schmidt H; Panknin S; Dotterer W
    J Immunol; 1983 Jul; 131(1):520-8. PubMed ID: 6223082
    [No Abstract]   [Full Text] [Related]  

  • 8. Modulation of cell-mediated cytotoxicity function after alteration of fatty acid composition in vitro.
    Bialick R; Gill R; Berke G; Clark WR
    J Immunol; 1984 Jan; 132(1):81-7. PubMed ID: 6197462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new method of immunosuppression by selective destruction of cytotoxic T cells with photodynamic effect.
    Sakurada M; Satomi S; Taguchi Y; Mori S
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):305-8. PubMed ID: 3279619
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro locomotion of allosensitized T lymphocyte clones in response to metabolites of arachidonic acid is subset specific.
    Jordan ML; Hoffman RA; Debe EF; Simmons RL
    J Immunol; 1986 Jul; 137(2):661-8. PubMed ID: 3013998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of cytotoxic T lymphocytes requires at least two spleen cell-derived helper factors besides interleukin 2.
    Falk W; Männel DN; Dröge W
    J Immunol; 1983 May; 130(5):2214-8. PubMed ID: 6220085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the induction and expression of T cell-mediated immunity. XIV. Antigen-nonspecific oxidation-dependent cellular cytotoxicity (ODCC) mediated by sodium periodate oxidation of cytotoxic T lymphocytes.
    Fan J; Bonavida B
    J Immunol; 1983 Sep; 131(3):1426-32. PubMed ID: 6193189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of cloned cytotoxic lymphocytes with NK-like activity.
    Acha-Orbea H; Groscurth P; Lang R; Stitz L; Hengartner H
    J Immunol; 1983 Jun; 130(6):2952-9. PubMed ID: 6189907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of T cell proliferation and cytotoxicity by lymphokines.
    Männel DN; Falk W; Dröge W
    Lymphokine Res; 1985; 4(2):133-8. PubMed ID: 3923276
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytolytic T lymphocyte effector function requires plasma membrane chloride flux.
    Gray LS; Russell JH
    J Immunol; 1986 Apr; 136(8):3032-7. PubMed ID: 3485679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptides derived from a wild-type murine proto-oncogene c-erbB-2/HER2/neu can induce CTL and tumor suppression in syngeneic hosts.
    Nagata Y; Furugen R; Hiasa A; Ikeda H; Ohta N; Furukawa K; Nakamura H; Furukawa K; Kanematsu T; Shiku H
    J Immunol; 1997 Aug; 159(3):1336-43. PubMed ID: 9233630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arachidonic acid metabolites and the in vivo allograft response: correlation with the development of allospecific cytotoxicity.
    Jordan ML; Carlson A; Hoffman R; Vidgen DF
    Transplant Proc; 1989 Apr; 21(2):3335-6. PubMed ID: 2540572
    [No Abstract]   [Full Text] [Related]  

  • 18. Capacity of different cell types to stimulate cytotoxic T lymphocyte precursor cells in the presence of interleukin 2.
    Dröge W; Moyers C; Wehrmaker A; Schmidt H; Panknin S; Männel D; Falk W
    J Immunol; 1984 Jun; 132(6):2749-59. PubMed ID: 6233360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purified hepatocytes can stimulate allospecific cytolytic T lymphocytes in a mixed lymphocyte-hepatocyte culture.
    So SK; Wilkes LM; Platt JL; Ascher NL; Simmons RL
    Transplant Proc; 1987 Feb; 19(1 Pt 1):251-2. PubMed ID: 3274778
    [No Abstract]   [Full Text] [Related]  

  • 20. Modulation of lymphocyte activation. I. Inhibition by an oxidation product of arachidonic acid.
    Goodman MG; Weigle WO
    J Immunol; 1980 Aug; 125(2):593-600. PubMed ID: 6156209
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.